In each cohort of KQ Labs, the Crick's start-up accelerator, ten companies working at the interface of data science and biomedical science spend five months learning new skills to help their company develop.
KQ Labs launched with its first cohort in 2018. Find out more about the companies who have taken part in the accelerator.
Our 2020/21 cohort
GLAMOROUS AI has a novel approach to chemical design and optimisation. Its proprietary platform, Rosalind, augments advanced ML with human expertise to enable applications where only limited data points are available.
Syrona is a personalised digital women's health screening and digital therapeutics platform, with a first focus on endometriosis.
Our 2019/20 cohort
Our 2018/19 cohort
ConcR focuses on cancer resistance and data driven predictions of patient outcome based on multi-omics data.
Head injuries are the leading cause of death and disability among the under 45s. Cortirio are developing portable brain imaging to diagnose head injuries at the point of care.
Deepscope is the first free ultrasound simulator for mobile devices. It enables healthcare professionals both to learn, using the free mobile app, and to teach, by easily creating their own clinical simulations.
Heron have created a graphical and navigable map of science, helping researchers, clinicians and industry gain more value from scientific literature.
Macular disease is the biggest cause of preventable sight loss in the developed world. Macusoft is developing clinical data and genomics based AI systems to support treatment to prevent avoidable blindness.
Mendelian accelerates the diagnosis of rare genetic diseases by building smart software solutions for clinicians, health providers and patients.
Okko are working on re-designing the eye chart. They are developing eye disease diagnosis and tracking through home monitoring.
Quin uses science, engineering and design to help people who take insulin make the best possible decisions.
Vesynta personalizes dosing of life-saving therapies through a desktop blood monitoring lab for rapid drug quantification, advancing medicines optimization and patient health outcomes.
ELU AI is unlocking the secrets of blood, addressing the problem of deteriorating patients with initial focus on Acute Kidney Injury